Exicure, Inc. (XCUR)
1.40
+0.03
(+2.19%)
USD |
NASDAQ |
Sep 11, 16:00
Exicure EPS Diluted (Quarterly) : -0.1759 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1759 |
| March 31, 2026 | -0.2868 |
| December 31, 2025 | -0.4547 |
| September 30, 2025 | -0.3855 |
| June 30, 2025 | -0.4149 |
| March 31, 2025 | 0.4868 |
| December 31, 2024 | -1.192 |
| September 30, 2024 | -0.5744 |
| June 30, 2024 | -0.3468 |
| March 31, 2024 | -0.4792 |
| December 31, 2023 | -0.8594 |
| September 30, 2023 | -3.038 |
| June 30, 2023 | -3.418 |
| March 31, 2023 | -3.504 |
| December 31, 2022 | 18.52 |
| September 30, 2022 | -5.198 |
| June 30, 2022 | -8.293 |
| March 31, 2022 | -10.35 |
| Date | Value |
|---|---|
| December 31, 2021 | -23.40 |
| September 30, 2021 | -40.06 |
| June 30, 2021 | -24.31 |
| March 31, 2021 | -21.30 |
| December 31, 2020 | -21.81 |
| September 30, 2020 | -15.17 |
| June 30, 2020 | -7.418 |
| March 31, 2020 | 1.954 |
| December 31, 2019 | -19.50 |
| September 30, 2019 | -13.49 |
| June 30, 2019 | -17.65 |
| March 31, 2019 | -17.88 |
| December 31, 2018 | -16.08 |
| September 30, 2018 | -19.23 |
| June 30, 2018 | -25.50 |
| March 31, 2018 | -21.00 |
| December 31, 2017 | -13.14 |
| September 30, 2017 | -167.91 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -0.35 |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | -0.1679 |
| Absci Corp. | -0.2109 |
| Celularity, Inc. | -0.8477 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.121M |
| Total Expenses (Quarterly) | 1.121M |
| Enterprise Value | 7.206M |
| Earnings Yield | -93.06% |
| Normalized Earnings Yield | -82.51 |